DRIO
DarioHealth Corp.
There isn't enough reported data to score DRIO yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
DRIO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Unavailable |
DRIO's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
DRIO PE Valuation
DRIO has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
DRIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect DRIO's losses to shrink, with revenue growing.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
DRIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$5.60 | +$33.20 |
| Q2 2024 | -$20.40 | +$21.40 |
| Q1 2024 | -$33.60 | +$11.40 |
| Q4 2023 | -$38.60 | +$12.20 |
LLY has the stronger earnings trend. Trailing diluted EPS is down 114% for DRIO versus LLY up 51%.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
DRIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.3M | +6.1% |
| Q2 2026 | $5.2M | -3.6% |
| Q1 2026 | $5.6M | -17% |
| Q4 2025 | $5.2M | -31% |
| Q3 2025 | $5M | -33% |
| Q2 2025 | $5.4M | -14% |
| Q1 2025 | $6.8M | +17% |
| Q4 2024 | $7.6M | +110% |
DRIO's revenue is recovering but still below its 2022 peak: $5M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -151% | +38 points |
| Q2 2026 | -125% | +46 points |
| Q1 2026 | -131% | +8.5 points |
| Q4 2025 | -164% | -10 points |
| Q3 2025 | -189% | -27 points |
| Q2 2025 | -171% | +88 points |
| Q1 2025 | -139% | +171 points |
| Q4 2024 | -153% | +240 points |
DRIO's operating margin was −151% last quarter, up 38 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over DRIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over DRIO on profitability, with a higher operating margin.
DRIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | +$1.8M |
| Q2 2026 | -$6.1M | -$46K |
| Q1 2026 | -$6.1M | +$648K |
| Q4 2025 | -$5.9M | +$840K |
| Q3 2025 | -$7.4M | -$2K |
| Q2 2025 | -$6.1M | +$5.3M |
| Q1 2025 | -$6.7M | +$6.5M |
| Q4 2024 | -$6.8M | +$671K |
DRIO has burned cash in almost every quarter: −$24M over the past year, against −$27M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over DRIO on cash generation, producing positive trailing cash flow while its opponent burns cash.
DRIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +29% | +2.7M shares |
| 1 year | +386% | +9.6M shares |
| 3 years | +756% | +10.7M shares |
| 5 years | +1620% | +11.4M shares |
DRIO has 12M diluted shares, up 386% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over DRIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
DRIO Net Leverage
DRIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
DRIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 1.0 | Oversold |
DRIO's weekly RSI is 20 (oversold) and its Stochastic is 1 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
DRIO PE vs Healthcare Sector
DRIO has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
DRIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 62% below |
| 20 week MA | $6.07 | 73% below |
| 50 week MA | $8.02 | 79% below |
| 100 week MA | $10.7 | 85% below |
| 200 week MA | $28.9 | 94% below |
DRIO is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over DRIO on trend strength, trading above more of its moving averages.
DRIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.0 | $263.4 | +109% |
| 2021 | $263.4 | $273.0 | +3.6% |
| 2022 | $273.0 | $79.8 | -71% |
| 2023 | $79.8 | $34.4 | -57% |
| 2024 | $34.4 | $13.9 | -60% |
| 2025 | $13.9 | $10.0 | -28% |
| 2026 YTD | $10.0 | $1.65 | -84% |
DRIO has finished four years in a row lower, and it's down 84% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over DRIO on returns for 2026, with the stronger performance.